Literature DB >> 9316732

Maturation of rubella IgG avidity over time after acute rubella infection.

B Böttiger1, I P Jensen.   

Abstract

BACKGROUND: As the incidence of rubella has diminished, the proportion of unspecific rubella IgM reactivity among all samples with rubella IgM reactivity has increased. It is important to distinguish IgM reactivity caused by primary infection from that caused by reinfection or persistence, especially in pregnant women, as termination of pregnancy should be considered when primary rubella is diagnosed during the first trimester.
OBJECTIVES: To elucidate the changes over time of the avidity of rubella IgG antibodies after acute rubella infection. STUDY
DESIGN: Serial samples, 84, were collected from 15 patients up to 4-5 months after acute rubella infection. Rubella specific IgG avidity was tested by the eluting principle adding 35 mM diethylamine to the washing buffer of a commercially available rubella IgG ELISA. As controls, 137 samples from women with remote rubella and 94 samples from patients with a rubelliform rash, were tested.
RESULTS: The avidity index increased steadily in all patients during the observation time. A low avidity index (< 40%) was seen up to 6 weeks after onset of rash. A high avidity index (> 60%) was not observed until 13 weeks after infection and only in four of the 15 patients during the observation time.
CONCLUSIONS: An increase of rubella IgG antibody avidity was seen during the whole observation time but was most pronounced during the first 3 months after onset of rash. Measurement of rubella IgG avidity is a good supplemental test for cases with rubella IgM reactivity to confirm or exclude a recent rubella infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9316732     DOI: 10.1016/s0928-0197(97)00018-4

Source DB:  PubMed          Journal:  Clin Diagn Virol        ISSN: 0928-0197


  12 in total

1.  Identification of Serologic Markers for School-Aged Children With Congenital Rubella Syndrome.

Authors:  Terri B Hyde; Helena Keico Sato; LiJuan Hao; Brendan Flannery; Qi Zheng; Kathleen Wannemuehler; Flávia Helena Ciccone; Heloisa de Sousa Marques; Lily Yin Weckx; Marco Aurélio Sáfadi; Eliane de Oliveira Moraes; Marisa Mussi Pinhata; Jaime Olbrich Neto; Maria Cecilia Bevilacqua; Alfredo Tabith Junior; Tatiana Alves Monteiro; Cristina Adelaide Figueiredo; Jon K Andrus; Susan E Reef; Cristiana M Toscano; Carlos Castillo-Solorzano; Joseph P Icenogle
Journal:  J Infect Dis       Date:  2014-10-31       Impact factor: 5.226

Review 2.  Interpretation of rubella serology in pregnancy--pitfalls and problems.

Authors:  Jennifer M Best; Siobhan O'Shea; Graham Tipples; Nicholas Davies; Saleh M Al-Khusaiby; Amanda Krause; Louise M Hesketh; Li Jin; Gisela Enders
Journal:  BMJ       Date:  2002-07-20

3.  Humoral immune response after primary rubella virus infection and after vaccination.

Authors:  C Vauloup-Fellous; L Grangeot-Keros
Journal:  Clin Vaccine Immunol       Date:  2007-03-07

4.  Rubella Surveillance and Diagnostic Testing among a Low-Prevalence Population, New York City, 2012-2013.

Authors:  Beth M Isaac; Jane R Zucker; Francesca R Giancotti; Emily Abernathy; Joseph Icenogle; Jennifer L Rakeman; Jennifer B Rosen
Journal:  Clin Vaccine Immunol       Date:  2017-09-05

5.  Utilization of follow-up specimens from viremic blood donors to assess the value of west nile virus immunoglobulin G avidity as an indicator of recent infection.

Authors:  Harry E Prince; Mary Lapé-Nixon; Michael P Busch; Leslie H Tobler; Gregory A Foster; Susan L Stramer
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

6.  Primary and probable secondary dengue virus (DV) infection rates in relation to age among DV IgM-positive patients residing in the United States mainland versus the Caribbean islands.

Authors:  Harry E Prince; Cindy Yeh; Mary Lapé-Nixon
Journal:  Clin Vaccine Immunol       Date:  2011-11-23

7.  Measles virus IgG avidity assay for use in classification of measles vaccine failure in measles elimination settings.

Authors:  Sara Mercader; Philip Garcia; William J Bellini
Journal:  Clin Vaccine Immunol       Date:  2012-09-12

8.  Development of a rapid and convenient method for determination of rubella virus-specific immunoglobulin G avidity.

Authors:  Christelle Vauloup-Fellous; Jessica Ursulet-Diser; Liliane Grangeot-Keros
Journal:  Clin Vaccine Immunol       Date:  2007-10-03

9.  Antibody avidity in humoral immune responses in Bangladeshi children and adults following administration of an oral killed cholera vaccine.

Authors:  Mohammad Murshid Alam; Daniel T Leung; Marjahan Akhtar; Mohammad Nazim; Sarmin Akter; Taher Uddin; Farhana Khanam; Deena Al Mahbuba; Shaikh Meshbahuddin Ahmad; Taufiqur Rahman Bhuiyan; Stephen B Calderwood; Edward T Ryan; Firdausi Qadri
Journal:  Clin Vaccine Immunol       Date:  2013-08-07

Review 10.  Standardization of Assays That Detect Anti-Rubella Virus IgG Antibodies.

Authors:  Wayne Dimech; Liliane Grangeot-Keros; Christelle Vauloup-Fellous
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.